ReachMD

ReachMD CME

Science EN ↓ 544 episoder

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Husk at besøge podcastens hjemmeside og støtte skaberen: reachmd.com

Forfatter

ReachMD

Kategori

Science

Podcastens hjemmeside

reachmd.com

Seneste episode

20. okt. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Installer gratis Android næsten 10 mio. downloads · 4,8 i bedømmelse iOS snart

Episoder

The Binder Selection Playbook: Matching the Right Strategy to the Right Patient 20.10.2026 17:15

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/the-binder-selection-playbook-matching-the-right-strategy-to-the-right-patient/70431/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures,...

From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection 20.10.2026 5:15

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/from-lab-alert-to-action-plan-monitoring-potassium-without-undermining-cardiorenal-protection/70430/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through ex...

CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia 20.10.2026 9:00

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/ckd-diabetes-and-albuminuria-keeping-kidney-protective-therapy-on-board-despite-hyperkalemia/70429/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through exp...

Potassium Binders to Optimize GDMT Therapy in HFrEF 20.10.2026 6:45

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/potassium-binders-to-optimize-gdmt-therapy-in-hfref/70428/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, interviews, and case-based...

The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion 20.10.2026 5:45

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/the-edema-question-selecting-a-potassium-binder-in-patients-with-hf-or-congestion/70427/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lecture...

Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load 20.10.2026 8:45

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/differentiating-oral-potassium-binders-mechanism-onset-and-sodium-load/70426/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, intervie...

Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex 20.10.2026 8:45

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/hyperkalemia-as-a-barrier-to-gdmt-why-stopping-gdmt-is-often-the-wrong-reflex/70425/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through expert lectures, i...

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs 20.10.2026 5:30

CME credits: 1.00 Valid until: 20-10-2027 Claim your CME credit at https://reachmd.com/cme/nephrology/personalized-treatment-strategies-for-hyperkalemia-bridging-evidence-and-clinical-practice-needs/48888/ This MinuteCE series examines practical approaches to hyperkalemia management in patients with chronic kidney disease (CKD), heart failure, diabetes, and other cardiorenal comorbidities. Through...

Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens 28.08.2026 3:45

CME credits: 0.50 Valid until: 27-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/translating-safety-data-into-practice-effective-ae-management-in-oral-serd-and-protac-regimens/67125/ Hear an expert discussion between Dr. Komal Jhaveri and Dr. Virginia Kaklamani as they examine the evolving role of oral selective estrogen receptor degraders (SERDs), including PROTACs and novel co...

The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape 28.08.2026 7:30

CME credits: 0.50 Valid until: 27-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/the-sequencing-puzzle-integrating-oral-serds-and-protacs-into-the-mbc-treatment-landscape/67124/ Hear an expert discussion between Dr. Komal Jhaveri and Dr. Virginia Kaklamani as they examine the evolving role of oral selective estrogen receptor degraders (SERDs), including PROTACs and novel combina...

Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression 28.08.2026 6:00

CME credits: 0.50 Valid until: 27-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/navigating-treatment-selection-after-first-line-cdk46-inhibitor-progression/67123/ Hear an expert discussion between Dr. Komal Jhaveri and Dr. Virginia Kaklamani as they examine the evolving role of oral selective estrogen receptor degraders (SERDs), including PROTACs and novel combination strategie...

Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders 28.08.2026 5:15

CME credits: 0.50 Valid until: 27-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/redefining-endocrine-therapy-the-evidence-behind-oral-serds-and-protac-er-degraders/67122/ Hear an expert discussion between Dr. Komal Jhaveri and Dr. Virginia Kaklamani as they examine the evolving role of oral selective estrogen receptor degraders (SERDs), including PROTACs and novel combination s...

Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy 26.08.2026 9:00

CME credits: 0.25 Valid until: 26-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/engaging-patients-with-heart-failure-and-chronic-hyperkalemia-shared-decision-making-to-support-guideline-directed-medical-therapy/37616/ In this Patient-Clinician Connection, Dr. Gianluigi Savarese uses a clinical case to demonstrate shared decision-making strategies for managing chronic and recurr...

Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients 24.08.2026 9:45

CME credits: 0.75 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-implementing-anti-cd38based-frontline-regimens-in-transplant-ineligible-patients/67248/ This online educational activity reviews the clinical evidence supporting anti-CD38 monoclonal antibody–based combinations as foundational frontline therapy for patients with newly diagnosed multiple...

Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma 24.08.2026 5:15

CME credits: 0.75 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/clinical-evidence-for-anti-cd38based-frontline-regimens-in-transplant-ineligible-patients-with-multiple-myeloma/60962/ This online educational activity reviews the clinical evidence supporting anti-CD38 monoclonal antibody–based combinations as foundational frontline therapy for patients with newly...

Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients 24.08.2026 9:15

CME credits: 0.75 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-implementing-anti-cd38based-frontline-regimens-in-transplant-eligible-patients/60961/ This online educational activity reviews the clinical evidence supporting anti-CD38 monoclonal antibody–based combinations as foundational frontline therapy for patients with newly diagnosed multiple m...

Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma 24.08.2026 5:30

CME credits: 0.75 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/clinical-evidence-for-anti-cd38based-frontline-regimens-in-transplant-eligible-patients-with-multiple-myeloma/60960/ This online educational activity reviews the clinical evidence supporting anti-CD38 monoclonal antibody–based combinations as foundational frontline therapy for patients with newly di...

Treating Outside the Box: New Pathways to Retinal Vascular Stability 24.08.2026 44:00

CME credits: 1.00 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/treating-outside-the-box-new-pathways-to-retinal-vascular-stability/56620/ Despite the well-known efficacy of anti-VEGF agents, a significant proportion of patients with DME or nAMD continue to show persistent or recurrent retinal fluid on OCT. This activity brings together expert faculty to discuss...

Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion 24.08.2026 16:00

CME credits: 0.25 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/ready-set-act-opportunities-to-address-persistent-unmet-needs-in-patients-with-hfref-a-case-based-discussion/57260/ Using a real-world patient case, Dr. Stephen Greene and Dr. Carolyn Lam explore strategies to optimize care for patients with heart failure with reduced ejection fraction (HFrEF) who r...

Winning the CKD-aP Battle: A United Physician-Nurse Front 17.08.2026 5:00

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/winning-the-ckd-ap-battle-a-united-physician-nurse-front/61000/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures...

What You Don’t See: A Patient’s View of Living with CKD-aP 17.08.2026 6:00

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/what-you-dont-see-a-patients-view-of-living-with-ckd-ap/60999/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...

Reading Between the Lines: What PROMs Reveal About Itch 17.08.2026 3:45

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/reading-between-the-lines-what-proms-reveal-about-itch/60998/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...

Spotlight on Assessment: Tools That Capture CKD-aP 17.08.2026 7:30

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/spotlight-on-assessment-tools-that-capture-ckd-ap/60997/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the s...

From Scratch to Strategy: Talking About CKD-aP in Clinical Practice 17.08.2026 5:00

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/from-scratch-to-strategy-talking-about-ckd-ap-in-clinical-practice/60996/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brie...

Gabapentinoids: Safety Considerations and Downstream Outcomes 17.08.2026 4:15

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/gabapentinoids-safety-considerations-and-downstream-outcomes/60995/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lect...